Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

January 22, 2021

Primary Completion Date

January 22, 2030

Study Completion Date

January 22, 2030

Conditions
Gastric Cancer
Interventions
OTHER

Molecular testing for all participants.

Molecular testing on formalin fixed paraffin-embedded (FFPE) tissues on retrospectively identified patients with gastric adenocarcinoma.

OTHER

Germline Testing

Germline testing will be done on prospectively identified patients and in retrospectively identified patients who are still alive.

OTHER

Survey

Survey will be administered on prospectively identified patients and in retrospectively identified patients who are still alive. Survey will be administered in person or via telephone. The survey in the language of the participants choice (English or Spanish) on sociodemographic information, current and/or prior PPI (proton pump inhibitor), H2 blocker, antibiotic, tobacco, alcohol, and recreational drug use. Questionnaire will include other risk factors for gastric adenocarcinoma such as certain dietary constituents (high salt diet, high consumption of processed meat, etc.) and occupational exposures.

Trial Locations (1)

78229

RECRUITING

Mays Cancer Center, UT Health San Antonio, San Antonio

All Listed Sponsors
collaborator

IIMS-UT Health San Antonio

UNKNOWN

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

The University of Texas Health Science Center at San Antonio

OTHER